ClinicalTrials.gg
WithdrawnNCT04186039BOLD FETUSUpdated Mar 12, 2026

Functional Evaluation of the Fetal Lung by Functional Magnetic Resonance Imaging - Blood Oxygenation Level Dependent (MRI-BOLD), in Congenital Diaphragmatic and Parietal Malformations

An interventional study of Functional magnetic resonance imaging - Blood Oxygenation Level Dependent in Congenital Diaphragmatic Hernia, Omphalocele and Gastroschisis, sponsored by Assistance Publique - Hôpitaux de Paris. Withdrawn at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-12.

Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Diagnostic

Why this study was withdrawn
Study manager's decision
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

The objective is to evaluate the quality of the response to the Blood Oxygen Level Dependent effect in fetuses with diaphragmatic hernias and abdominal wall malformations and to correlate with postnatal respiratory outcome. Pulmonary involvement is a constant in diaphragmatic hernias, it is classic in omphaloceles and especially hepatomphaloceles, and exceptional in laparoschisis. As this is an original exploratory study, no preliminary data are available.

If a correlation is found, the Blood Oxygen Level Dependent effect of the fetal lung may be considered as an early functional marker of postnatal lung function. It can be used in addition to lung-to-head-ratio during prenatal counseling.

The final goal is to be able to detect early in the fetus pulmonary insufficiency to help prenatal counseling and perinatal care.

Read the detailed description

During the fetal period, there is in the lungs a permanent flow and pressure variations between the "inhaled" amniotic fluid and alveolar secretions, which are essential for pulmonary development. A disruption of this physiological mechanism can induce disorders of the respiratory function, which go from simple delay of maturation to hypoplasia. Respiratory function involves the thoracic muscles (diaphragmatic and intercostal) but also the abdominal muscles, that explains why breathing difficulties are found at birth in neonates with diaphragmatic hernia but also abdominal wall malformations.

This pulmonary involvement highly contributes to the morbidity observed at birth, for which strong prenatal predictive criteria are lacking.

Pulmonary volume measurement by the lung-to-head-ratio is widely used for diaphragmatic hernia has been extended to other congenital malformations, because no other available criteria. The lung-to-head-ratio is a parameter well correlated with survival but insufficiently with morbidity and sequelae.

New functional imaging techniques are in development. Among them, the Blood Oxygen Level Dependent uses hemoglobin as an endogenous contrast agent. It is based on the comparison of a basic status in ambient air with status after oxygenation. It gives a functional evaluation of the organs. But this technique has never been evaluated in the fetal lung yet.

The objective of the study is to evaluate the quality of the response to the Blood Oxygen Level Dependent effect in fetuses with diaphragmatic hernias and abdominal wall malformations and to correlate with postnatal respiratory outcome. It is an original exploratory study and no preliminary data are thus available.

If a correlation is found, the Blood Oxygen Level Dependent effect of the fetal lung may be considered as an early functional marker of postnatal lung function. It could then be used in addition to lung-to-head-ratio during prenatal counseling. The final goal is to be able to detect early in the fetus pulmonary insufficiency to help prenatal counseling and perinatal care.

02

Conditions studied

  • Congenital Diaphragmatic Hernia
  • Omphalocele
  • Gastroschisis

Keywords

  • Functional magnetic resonance imaging
  • Blood Oxygen Level Dependent effect
  • Congenital diaphragmatic hernia
  • Omphalocele
  • Gastroschisis
  • Fetal lung
  • Respiratory failure
03

In context

Hernias, Diaphragmatic, Congenital

86 studies on the registry are indexed under Hernias, Diaphragmatic, Congenital; 39 are open to participants now.

Browse Hernias, Diaphragmatic, Congenital studies →

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,592 studies on the registry; 1,033 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Major patient,
  • patient with a simple pregnancy,
  • patient between 28 and 33 weeks of amenorrhea,
  • patient undergoing fetal MRI as part of their usual care, for fetal / placental indications : diaphragmatic hernia, omphalocele and laparoschisis,
  • signed by the patient and the investigator,
  • patient affiliated to a social security scheme (beneficiary or beneficiary).

Exclusion criteria

Exclusion Criteria:

  • Patient with one of the usual for MRI,
  • claustrophobic patient,
  • patient with an abdominal perimeter> 125 cm,
  • patient with multiple-birth pregnancy,
  • patient with a pregnancy at the end of a long course of medical assisted procreation,
  • patient with chronic respiratory disease.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Congenital diaphragmatic and parietal malformations

    Patients with fetal magnetic resonance imaging as part of their usual medical care, for fetal / placental indications of diaphragmatic hernia, omphalocele or gastroschisis.

    Diagnostic Test: Functional magnetic resonance imaging - Blood Oxygenation Level Dependent

Interventions

  • Diagnostic testFunctional magnetic resonance imaging - Blood Oxygenation Level Dependent

    First Functional magnetic resonance imaging - Blood Oxygenation Level Dependent sequence under ambient air. Oxygenation of 5 minutes at a rate of 12 l / min. Second Functional magnetic resonance imaging - Blood Oxygenation Level Dependent sequence.

06

What researchers measure

Primary outcomes

  1. Value of the Blood Oxygenation Level Dependent of the fetal lung

    Regions of interest (ROI) were manually identified on MRI images, with the largest possible homogenous 2D area. For the lungs, the ROIs were delineated at the maximal chest circumference, delineating the right lung, the left lung. Changes in haemoglobin concentration will be evaluated by the variation in transverse R2\* signal induced by oxygenation in the delimited ROI. The BOLD response will be calculated for each case as the difference between normoxic and hyperoxic period (∆R2\*) normalized by normoxic value: ∆R2\* = \[R2\*(norm)-R2\*(hyper)\] / R2\*(norm).

    Time frame: 30 months

  2. Postnatal respiratory evolution

    Duration of mechanical ventilation

    Time frame: 30 months

Secondary outcomes

  1. Postnatal survival

    Survival rate at 30 days after birth

    Time frame: 30 months

  2. Duration of oxygen dependence

    Total days of oxygen requiring

    Time frame: 30 months

  3. Length of hospitalization

    Total days of the neonatal hospitalization before discharge

    Time frame: 30 months

07

Study locations

1 site
  • Hôpital Necker-Enfants Malades
    Paris, 75015, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04186039
Collaborators
Filière des Maladies Rares Abdomino-THOraciques : FIMATHO, URC-CIC Paris Descartes Necker Cochin
Responsible party
Sponsor
First posted
Dec 4, 2019
Start date
May 2020 (estimated)
Primary completion
May 2022 (estimated)
Completion
May 2022 (estimated)
Last update
Mar 12, 2026

Study contacts

Naziha KHEN-DUNLOP, MD, PhD
principal investigator · Assistance Publique - Hôpitaux de Paris
Laurent SALOMON, MD
study director · Assistance Publique - Hôpitaux de Paris

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion